Skip to main content
Fig. 5 | Epigenetics & Chromatin

Fig. 5

From: Genome-wide methylation analysis demonstrates that 5-aza-2-deoxycytidine treatment does not cause random DNA demethylation in fragile X syndrome cells

Fig. 5

Comparison between samples with respect to GO terms. In a is reported the comparison between WT1 and WT2 versus untreated FXS1. Note the enrichment of DMRs for only three GO terms. There is a broad distribution of DMRs over several GO terms in the comparison between WT1 and WT2 versus FXS2, although it is possible to identify two major enriched ones (anatomical structure development and cellular nitrogen compound metabolic process) (b)

Back to article page

Epigenetics & Chromatin

ISSN: 1756-8935